| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.005 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |